Literature DB >> 19403487

Biliary atresia screening: why, when, and how?

Ronald J Sokol1.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19403487      PMCID： PMC3881183          DOI： 10.1542/peds.2008-3108

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  8 in total

Review 1.  Unraveling the pathogenesis and etiology of biliary atresia.

Authors:  Cara L Mack; Ronald J Sokol
Journal:  Pediatr Res       Date:  2005-04-06       Impact factor: 3.756

2.  A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000.

Authors:  Benjamin L Shneider; Morton B Brown; Barbara Haber; Peter F Whitington; Kathleen Schwarz; Robert Squires; Jorge Bezerra; Ross Shepherd; Philip Rosenthal; Jay H Hoofnagle; Ronald J Sokol
Journal:  J Pediatr       Date:  2006-04       Impact factor: 4.406

3.  Seamless management of biliary atresia in England and Wales (1999-2002).

Authors:  Mark Davenport; J De Ville de Goyet; M D Stringer; G Mieli-Vergani; D A Kelly; P McClean; L Spitz
Journal:  Lancet       Date:  2004-04-24       Impact factor: 79.321

4.  Impact of age at Kasai operation on its results in late childhood and adolescence: a rational basis for biliary atresia screening.

Authors:  Marie-Odile Serinet; Barbara E Wildhaber; Pierre Broué; Alain Lachaux; Jacques Sarles; Emmanuel Jacquemin; Frédéric Gauthier; Christophe Chardot
Journal:  Pediatrics       Date:  2009-05       Impact factor: 7.124

5.  Prolonged neonatal jaundice and the diagnosis of biliary atresia: a single-center analysis of trends in age at diagnosis and outcomes.

Authors:  Sharad I Wadhwani; Yumirle P Turmelle; Rosemary Nagy; Jeffrey Lowell; Patrick Dillon; Ross W Shepherd
Journal:  Pediatrics       Date:  2008-04-28       Impact factor: 7.124

6.  Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.

Authors: 
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

Review 7.  Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop.

Authors:  Ronald J Sokol; Ross W Shepherd; Riccardo Superina; Jorge A Bezerra; Patricia Robuck; Jay H Hoofnagle
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

8.  Universal screening for biliary atresia using an infant stool color card in Taiwan.

Authors:  Cheng-Hui Hsiao; Mei-Hwei Chang; Huey-Ling Chen; Hung-Chang Lee; Tzee-Chung Wu; Chieh-Chung Lin; Yao-Jong Yang; An-Chyi Chen; Mao-Meng Tiao; Beng-Huat Lau; Chia-Hsiang Chu; Ming-Wei Lai
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425
  8 in total
  2 in total

1.  Factors Influencing Time-to-diagnosis of Biliary Atresia.

Authors:  Sanjiv Harpavat; Philip J Lupo; Loriel Liwanag; John Hollier; Mary L Brandt; Milton J Finegold; Benjamin L Shneider
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-06       Impact factor: 2.839

2.  Screening for biliary atresia: it's in the cards.

Authors:  Richard A Schreiber; Alison Butler
Journal:  Can Fam Physician       Date:  2017-06       Impact factor: 3.275
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.